🔎 Trials Near Me

홈 › 자궁내막암 › 테네시

테네시의 자궁내막암 임상 시험

자궁내막암 관련 연구 41개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.

테네시의 도시

공식 연구 텍스트(영어)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
  • Regional Cancer Center at Johnson City Medical Center, Johnson City
  • Ballad Health Cancer Care - Kingsport, Kingsport
  • 외 3개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Vanderbilt-Ingram Cancer Center Cool Springs, Franklin
  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중3상
18세 이상 · 여성 · 2026. 10. 2. 업데이트됨 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07419841

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • Sarah Cannon Research Institute (SCRI), Nashville
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

DESTINY-PANTUMOUR04

  • Research Site, Nashville
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Nashville
피험자 모집 중2상
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Sarah Cannon Research Institue, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Sarah Cannon - Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Erlanger Medical Center ( Site 5009), Chattanooga
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Sarah Cannon Nashville, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  • GSK Investigational Site, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07213609

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT07755436

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06515613

Endometrial Cancer Vaginal Fluid Specimen Collection Study

  • Murfreesboro Medical Clinic, Murfreesboro
  • IC Research, Murfreesboro
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2026. 8. 27. 업데이트됨 · NCT07544680

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • SCRI Oncology Partners - Nashville, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
피험자 모집 중1/2상
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06840886

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Erlanger Health, Inc, Chattanooga
  • The West Clinic, Germantown
  • SCRI Oncology Partners, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • Sarah Cannon Research Institute at Tennessee Oncology, Nashville
  • Tennessee Oncology, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Tennessee Oncology, PLLC, Chattanooga
  • SCRI Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Knoxville
  • Research Site, Nashville
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT06695845

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • The West Clinic, PLLC dba West Cancer Center, Germantown
  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Sarah Cannon Research Institute (SCRI), Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07046923

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT07503808

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06239194

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist (BHMCC), Memphis
  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Memphis
  • Massive Bio SYNERGY-AI site, Nashville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Tennessee Oncology, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.